| Literature DB >> 26491267 |
Ammar Almaaytah1, Tareq L Mukattash2, Julia Hajaj2.
Abstract
OBJECTIVE: Current regulations in Jordan state that antibiotics cannot be sold without a medical prescription. This study aimed to assess the percentage of pharmacies that dispense antibiotics without a medical prescription in the Kingdom of Jordan and identify and highlight the extent and seriousness of such practices among Jordanian pharmacies.Entities:
Keywords: Jordan; microbial resistance; non-prescribed antibiotics; pharmacy; pharmacy practice
Year: 2015 PMID: 26491267 PMCID: PMC4599149 DOI: 10.2147/PPA.S91649
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Percentage of pharmacies dispensing antibiotics with no prescription with regard to level of demand
| Level of demand | Sore throat, n=41 | Acute sinusitis, n=39 | Otitis media, n=38 | Diarrhea, n=42 | UTI, n=42 | Total, n=202 |
|---|---|---|---|---|---|---|
| Level one | 39 (95.1%) | 3 (7.7%) | 25 (65.8%) | 24 (57.1%) | 30 (71.4%) | 121 (59.9%) |
| Level two | 0 (0%) | 4 (10.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (2%) |
| Level three | 1 (2.4%) | 8 (20.5%) | 1 (2.6%) | 10 (23.8%) | 5 (11.9%) | 25 (12.4%) |
| Total | 40 (97.6%) | 15 (48.5%) | 26 (68.4%) | 34 (81%) | 35 (83.3%) | 150 (74.3%) |
Notes: Level 1, represents the lowest level of demand as the investigator asked for something to alleviate the symptoms; while Level 3 represents the highest level of demand by directly asking the pharmacist for an antibiotic.
Abbreviation: UTI, urinary tract infection.
Pharmacists’ inquiries and recommendations in response to the simulated clinical scenarios
| Simulated clinical scenario | Explained how to take the antibiotic | Explained the duration of treatment | Asked about drug allergy | Asked about concomitant use of other drugs | Recommended consulting a physician | Dispensed antibiotic |
|---|---|---|---|---|---|---|
| Sore throat, n=40 | 35 (87.5%) | 7 (17.5%) | 18 (45%) | 1 (2.5%) | 0 (0%) | Penicillins (45%) |
| Penicillin/penicillinase inhibitor (32.5%) | ||||||
| First-Gen cephalosporins (10%) | ||||||
| Acute sinusitis, n=15 | 14 (93.3%) | 1 (6.7%) | 4 (26.7%) | 4 (26.7%) | 0 (0%) | Penicillins (20%) |
| Fluoroquinolones (20%) | ||||||
| Macrolides (20%) | ||||||
| Otitis media, n=26 | 26 (100%) | 3 (11.5%) | 0 (0%) | 3 (11.5%) | 4 (15.4%) | Choramphenicol (19.2%) |
| Penicillins (15.4%) | ||||||
| Macrolides (11.5%) | ||||||
| Diarrhea, n=34 | 34 (100%) | 7 (20.6%) | 0 (0%) | 0 (0%) | 1 (2.9%) | Antiprotozoals (79.4%) |
| Sulfonamides (5.9%) | ||||||
| FQ (2.9%) | ||||||
| UTI, n=35 | 34 (97.1%) | 7 (20%) | 1 (2.9%) | 0 (0%) | 1 (2.9%) | Fluoroquinolones (80%) |
| Third-Gen cephalosporins (5.7%) |
Abbreviations: UTI, urinary tract infection; Gen, generation; FQ, fluoroquinolones.
The percentage of antibiotic dispensing refusal and recommendations
| Sore throat, n=1 | Acute sinusitis, n=24 | Otitis media, n=12 | Diarrhea, n=8 | UTI, n=7 | Total, n=52 | |
|---|---|---|---|---|---|---|
| Antibiotic dispensing refusal based on health concerns | 1 (100%) | 24 (100%) | 12 (100%) | 8 (100%) | 7 (100%) | 52 (100%) |
| Recommended medical evaluation | 0 (0%) | 3 (14.3%) | 9 (75%) | 1 (12.5%) | 6 (85.7%) | 19 (36.5%) |
Abbreviation: UTI, urinary tract infection.